119 related articles for article (PubMed ID: 16702812)
1. Octahedral Pt(IV) complex K101 induces apoptosis via ERK1/2 activation and the p53 pathway in human colon cancer cells.
Kwon YE; Kim KH
Anticancer Drugs; 2006 Jun; 17(5):553-8. PubMed ID: 16702812
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
4. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
Rice PL; Peters SL; Beard KS; Ahnen DJ
Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
[TBL] [Abstract][Full Text] [Related]
5. Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling.
Silva SLR; Baliza IRS; Dias RB; Sales CBS; Rocha CAG; Soares MBP; Correa RS; Batista AA; Bezerra DP
Sci Rep; 2019 Jul; 9(1):11094. PubMed ID: 31366902
[TBL] [Abstract][Full Text] [Related]
6. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
Kwon YE; Park JY; Kim WK
Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
[TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
[TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
9. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
[TBL] [Abstract][Full Text] [Related]
10. Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells.
Jeon HK; Choi SU; Jung NP
Cell Biol Toxicol; 2005 Mar; 21(2):115-25. PubMed ID: 16142585
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; Barca A; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2017; 12(7):e0181114. PubMed ID: 28704484
[TBL] [Abstract][Full Text] [Related]
12. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
14. Palmitate induces H9c2 cell apoptosis by increasing reactive oxygen species generation and activation of the ERK1/2 signaling pathway.
Wei CD; Li Y; Zheng HY; Tong YQ; Dai W
Mol Med Rep; 2013 Mar; 7(3):855-61. PubMed ID: 23338747
[TBL] [Abstract][Full Text] [Related]
15. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer.
Yu LF; Wang J; Zou B; Lin MC; Wu YL; Xia HH; Sun YW; Gu Q; He H; Lam SK; Kung HF; Wong BC
Cancer; 2007 May; 109(10):1996-2003. PubMed ID: 17385215
[TBL] [Abstract][Full Text] [Related]
16. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
17. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
18. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells.
Yano S; Wu S; Sakao K; Hou DX
Biosci Biotechnol Biochem; 2019 May; 83(5):960-969. PubMed ID: 30730256
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
20. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
Wang X; Li M; Wang J; Yeung CM; Zhang H; Kung HF; Jiang B; Lin MC
Biochem Pharmacol; 2006 May; 71(11):1540-50. PubMed ID: 16595125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
